Agenda

5 mins Welcome and Introductions
50 mins Feature Lecture: Revolutionizing the Paradigm and Prognosis of B-Cell Malignancies with BTK Inhibitors
5 mins Audience Q&A

Target Audience

Practitioners involved in the care of patients with B-cell malignancies, including oncologists, hematologists, oncology/hematology residents/fellows, oncology specialty nurse practitioners, nurses, nurse navigators, physician assistants, and pharmacists.